Arena Pharma raises $33M

Arena Pharmaceuticals ($ARNA) is raising $33 million in a stock sale. Deerfield Management, a healthcare investment organization, is buying the shares for $1.65 each. Arena recently submitted new information to the FDA for its obesity drug lorcaserin, hoping to become the first drug developer to win an approval for a weight drug in more than a decade. Arena release